Medtronic

Industry / private company


Location: Minneapolis, United States (USA) (US) US

ISNI: 0000000095452456

ROR: https://ror.org/00grd1h17

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Influence of Gender on Blood Pressure Reduction After Renal Denervation in GSR DEFINE (2022) Weil J, Mahfoud F, Schmieder R, Narkiewicz K, Williams B, Fahy M, Mancia G Conference contribution Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry (2022) Schmieder R, Mahfoud F, Mancia G, Narkiewicz K, Ruilope L, Hutton D, Cao K, et al. Journal article Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial (2022) Weber MA, Schmieder R, Kandzari DE, Townsend RR, Mahfoud F, Tsioufis K, Kario K, et al. Journal article Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial (2022) Weber T, Wassertheurer S, Mayer CC, Hametner B, Danninger K, Townsend RR, Mahfoud F, et al. Journal article LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS (2022) Tsioufis K, Kandzari D, Kario K, Townsend R, Mahfoud F, Weber M, Schmieder R, et al. Conference contribution LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS (2022) Tsioufis K, Kandzari D, Kario K, Townsend R, Mahfoud F, Weber M, Schmieder R, et al. Journal article Reduction of Clinical Events in High-Risk Hypertension Patients Treated With Renal Denervation: A Modeled Estimate From 36-Month Global SYMPLICTY Registry Data (2022) Schlaich M, Pietzsch JB, Mahfoud F, Wiliams B, Mancia G, Narkiewicz K, Ruilope L, et al. Conference contribution Physician Preferences for Recommending Renal Denervation to Hypertensive Patients Is Influenced by Patients' Antihypertensive Medication Nonadherence Due to Medication Side Effects (2022) Wang TD, Schmieder R, Kandzari DE, Lee YH, Haro CF, Pathak A Conference contribution Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022) Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Journal article Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years (2022) Ott C, Mahfoud F, Mancia G, Narkiewicz K, Ruilope LM, Fahy M, Schlaich MP, et al. Journal article
1 2 3 4 5